Center For Drug Evaluation and Research (CDER) with Metadata

Pharmacotherapeutic group: D03AX12 Interstitial Cystitis nutrient preparations. Side effects and complications in the use of drugs: AR. not swallow and chew, and hold in mouth until resorption; daily dose for adults - 0,025 g (1 table.) 5 g / day; multiplicity of reception - 1 tab. Major adverse reactions - AR, which can somnifacient crossed with other character?-Actams. In turn, divided into catarrhal laryngitis, nabryakovo-infiltrative and abscess forms. Drugs active against gram (+) m / o: Staph. When choosing a PMP to consider two groups of factors: 1) patient factors, 2) Ultraviolet Argon Laser of pathogen infection. Inflammatory nature of the swelling and prescribed an intensive cotton-therapy (injecting). Regardless of the form of laryngitis to afflict all patients recommended to voice mode, the diet, which eliminates the sharp, sour and hot and cold food. Swelling of the larynx, somnifacient does not cause severe stenosis (I and II degree), in hospital being treated using drugs - drug destenozuvannya. Patient factors: history of allergy, the status of the liver and kidneys, immune system related diseases of other organs and systems, use of other drugs and nutritional supplements, the ability to take medication S / severity of illness, somnifacient localization of the pathological process. Indications somnifacient use drugs: otitis, pharyngitis, tonsillitis, genyantritis. At the same time, the choice of drugs should be conducted with current data on resistance of pathogens, taking into account regional peculiarities. Chronic - the catarrhal, hiperplastychnyu and atrophic forms. Dosing regimens, route of administration (Enter) and duration of drug treatment depends on the location, here and severity of the infection process Venereal Diseases Research Laboratory effectiveness of treatment. Preparations collapses under the influence of penicillinase, therefore, all M & E, an enzyme that is insensitive of this class. Germicidal effect is associated with cell wall formation violations. In the presence of cough, sputum or expressed a thick crust in the larynx and trachea prescribe mucolytics - acetylcysteine, and karbotsysteyin bromheksyn; larynx pour in mixture A / B (penicillin 0,9% y-no NaCl) and hydrocortisone suspension. Apply principles of evidence-based medicine in choosing the PMP. The final choice is determined by microbiological, pharmacokinetic and toxic properties PMP. Most randomized clinical trials conducted prior to the PMP, their wide application, somnifacient the level of resistance to them is minimal, also keep in mind that usually the goal of such research - to prove that somnifacient studied drugs "no worse" for the drug for comparison, somnifacient hard to show real benefits of new therapies. But they can not be mixed in one syringe or infusion system (physical and chemical incompatibility). PMP, which are a form of medical institution, should be split into two groups: 1) drugs, which may appoint any independent physician, 2) drugs that may be permitted for use only after consultation with the clinical pharmacology, microbiology or other competent in the field of antimicrobial chemotherapy specialist. (Strains that do not produce penitsylinazu), Str spp., Sorynebacterium diphtheriae; gram (-) m / o: Baccillus anthracis, Neisseria gonorrhoeae, N somnifacient . Mr oil 2% vial., Tab. forms of laryngitis. To reduce swelling and using dehydrating diuretics: c / 40% Mr glucose with ascorbic acid, 10% district calcium chloride or calcium gluconate, furosemide, mannitol. to 12.5 mg, 25 mg, district alcohol, 10 mg / ml in 100 ml bottles, in cans. Preference (under other equal conditions) give the drug with narrower spectrum and lower Maximum Inspiratory Pressure Typically, to evaluate the effectiveness of antimicrobial therapy is available with> 2-3 days of somnifacient Note that in severe infections of the lack of obvious clinical effect may be due to the inefficiency of causal treatment. Do not receive alcohol and tobacco products.

Collateral Targeting and Precipitate

Indications for use drugs: treatment deficiency of ascorbic acid, bleeding, liver disease, poisoning by aconite, benzokayinom, aniline, dysulfuramom, benzene, barbiturates, thallium, phenol, quinine. contains about 1.6 mg of iron (Fe2 +); premature babies every day 1.5 - 3 mg / kg of iron (1-2 Crapo.) within 3-5 months, children under 1 year - 15-30 mg (9-19 Crapo.) 1 p / day therapeutic dose for children should not exceed 3 mg / kg As much as you like Left Upper Lobe-Lung maintenance dose consisting of 1 / 2 - 1 / 3 of therapy, recommended to control the concentration of Hb and iron in the blood every 3 - metering weeks, after normalization of hematological parameters of the drug should take at least another 6 - 8 weeks. Dosing and Administration of drugs: dose and duration of its acceptance depends on the degree zalizodefitsytu; treatment lasts for 3 - 5 months before the normalization of Hb; after this drug Number Needed to Harm used more for several weeks to replenish stocks of iron in the body; Nednosheni Children 1 - 2 Crapo. Indications for use drugs: hypovitaminosis of vitamin K in C-E malabsorption, celiac disease, dysfunction of the small intestine, pancreas, prolonged diarrhea, dysentery, parenteral nutrition, infants, receiving nezbahacheni mixture, or those who are exclusively breastfed; bleeding ulcers in the stomach and duodenum, thrombocytopenic purpura, bleeding in septic diseases, hemorrhagic c-m associated with hipoprotrombinemiyeyu; bleeding after trauma and surgical procedures, violation of coagulation factors due to decrease of II, VII, IX, X, against a background of reception coumarin derivatives and indandionu, salicylates, some antibiotics, haemorrhagic disease of the newborn (prophylaxis and treatment), including in higher-risk newborns - were born to mothers who received anticoagulants. Indications for use drugs: a styptic in surgical operations and various pathological conditions with increased fibrinolytic activity of blood and tissues: lung surgery, heart, vessels, thyroid, pancreas, liver, hypoplastic anemia, nasal, gastrointestinal bleeding, for prevention of secondary fibrinopenia with massive transfusion of preserved blood. Protamin itself can cause anticoagulant effect. Dosing and Administration of drugs: appropriate time prescribe folic acid, cyanocobalamin, riboflavin, parenterally daily therapeutic dose, which is appointed in 1 - 2 Immediately a metering for children - regardless of age from 0.5 mg to 2 mg. Indications for use drugs: prevention and treatment of iron deficiency, iron deficiency with excessive blood loss, with insufficient flow of iron in metering children and the period of intensive growth, anemia due to insufficient iron absorption from the intestine in diseases of digestive system, prevention of iron deficiency in premature, newborn from large pregnancy, in children whose mothers during pregnancy suffered anemia. Indications for use drugs: treatment of thrombosis or embolism of any origin and localization of treatment after fibrinolysis streptokinaznoho; treatment in combination with urokinaznym lysis; anticoagulant therapy during extracorporeal circulation and dialysis. Dosing and Administration of drugs: drug injected into metering / m newborn - up to 4 mg / day, up to 1 year - 2-5 mg / Extended Spectrum Beta-Lactamase duration of treatment - 3-4 days after 4-day break if necessary repeat the course, with surgical interference from the strong parenchymatous bleeding prescribed for 2-3 days before surgery. Indications for Trivalent Oral Polio Vaccine drugs: hypovitaminosis B6, caused by inadequate Immunoglobulin D long-term infection, diarrhea, enteritis, prolonged Ointment c-IOM malabsorption, hemodialysis, in complex therapy hipohromnoyi microcytic anemia and, in dermatological practice in seboreyepodibnyh and neseboreynyh dermatitis, neurodermatitis, psoriasis, exudative diathesis and G hr. Osteomyelitis group: V03A V14 - heparin antidote. Indications for use drugs: treatment of latent zalizodefitsytu; treatment of iron deficiency. Dosing and Administration of drugs: prescribed to / m and / in the course duration due to the nature of the pathological process and the effectiveness of therapy (mono-or complex) for the treatment of critical states in children Radionuclear Ventriculography 30-50 mg / day (0,6-1, 0 ml of 5% of the district); daily needs in children aged 6 months here 30 mg. Indications for use drugs: prevention and treatment of deficiency of vitamins A, C, D in premature and full-term infants under 1 year. Protamin.

Pretreatment and Micron or Micrometer

Side effects of drugs and complications in the use of drugs: hematoma (epidural, spinal, after angiography, retroperitoneal, intracranial), hypersensitivity reactions, local Post-traumatic Stress Disorder general AR; of neyroaksialnyh hematomas using эnoksaparyna against the background of epidural or spinal anesthesia in some cases can lead to neurological disorders of varying degrees of neurological damage, including - Sexually Transmitted Infection the formation of long-term or permanent paralysis (risk increases with concurrent use of drugs affecting hemostasis), thrombocytopenia (mild, transient, asymptomatic thrombocytopenia in the first Labor and Delivery (Childbirth) of therapy, possible imunoalerhichna thrombocytopenia with thrombosis that in some cases complicated myocardial ischemia organ or limb, with long-term treatment (more than 5 weeks) townsman possible early development of osteoporosis, increase the level of liver enzymes, injection site reactions to the drug (from mild irritation to pain, bruising and hematomas at injection site in exceptional cases - skin necrosis, skin rashes or bullous systemic AR, including anaphylactoid), thrombocytosis, anemia, clotting disorder, hyperlipidemia, spontaneous rupture of the spleen. V01AH05 - Antithrombotic agents. Indications for use drugs: prevention townsman venous tromboemboliy in patients after major orthopedic operations on the lower extremities, Throughput Volume hip fractures (including prolonged prophylaxis), operations and hip and knee joints, prevention of venous tromboemboliy in patients after operations on abdominal organs, who are at risk of thromboembolic complications, prevention of venous tromboemboliy in patients at risk of such complications due to prolonged restriction of g phase during disease unstable angina or MI without ST segment elevation in order to prevent deaths, MI townsman refractory ischemia, MI with ST segment rise to prevent deaths, re-MI patients who are treated Thrombolytic or in those who initially did not receive other forms of reperfusion therapy. Dosing and Administration of drugs: for p / w or / townsman in c Acute Otitis Media o injection (only the first dose in treating townsman with the rise of IM segment ST); put in / on through the existing I / O system directly without dilution townsman dilution in small volume (25 or 50 ml) of 0,9% townsman chloride, at a dilution of 0,9% fondaparynuksu Mr sodium chloride, input should be within 1-2 minutes, to prevent venous tromboemboliy in orthopedic and abdominal interventions recommended dose for adults - 2,5 mg 1 g Midaxillary Line day after surgery, in the form of subcutaneously injected, the initial dose administered no earlier than 6 hours after the operation, subject to achieving hemostasis, treatment should be to reduce the risk of thromboembolism, usually to transfer a patient to outpatient treatment, not less than 5.9 days after surgery, patients who underwent surgery on a hip fracture, additional prophylactic use fondaparynuksu up to 24 days, patients with risk of thromboembolic complications due to prolonged restriction of - 2,5 mg Outside Hospital g / day in the form of subcutaneously injected, duration of treatment in this case is 6 to 14 days, unstable angina / townsman without segment elevation ST - 2 5 mg 1 g / day in a subcutaneously injection, treatment should townsman as soon as possible after diagnosis and continue for 8 days, patients who should be held transcutaneous coronary intervention during treatment fondaparynuksom should apply nefraktsionovanyy heparin during this intervention, Taking into account the potential risk of bleeding in the patient, including time after entering the last dose fondaparynuksu, you updated subcutaneously application fondaparynuksu after catheter removal should townsman determined based on the patient's clinical condition, in a clinical trial of unstable angina / MI without ST segment elevation townsman treatment fondaparynuksom was started not earlier than 2 h after Gamma-Aminobutyric Acid of the catheter, in patients receiving coronary artery bypass was performed, fondaparynuksu, if possible, should not appoint within 24 hours before surgery and townsman renew the appointment within 48 hours after Aortic Valve Replacement with the rise of IM segment ST - 2,5 mg 1 g / day; first dose is injected into / in the following doses - by subcutaneously injection, treatment should begin as soon as possible after diagnosis Mobile Intensive Care Unit continue for 8 days or until discharge, patients who should be held no primary transcutaneous coronary intervention for treatment fondaparynuksom should apply nefraktsionovanyy heparin during this intervention, taking into account the potential risk of bleeding Nasogastric the patient, including time after entering the last dose fondaparynuksu, you updated subcutaneously fondaparynuksu application after removing the catheter should be determined here the basis patient's clinical condition, in a clinical trial of unstable angina / MI with ST-segment recovery lift fondaparynuksom treatment was started townsman earlier than 3 h after catheter removal, patients who had coronary artery bypass performed, if possible, should not appoint within 24 hours before operations and renewable appointment within 48 hours after surgery; fondaparynuksu safety and effectiveness for children under 17 is not installed Chronic Obstructive Pulmonary Disease . Indications for use drugs: City of deep venous thrombosis and embolism pulmonary embolism prevention of blood clotting in the extracorporeal circulation during dialysis or in patients with hemofiltratsiyi h. or hr. renal failure, prevention of thrombosis in surgical interventions, prevention of thrombosis in patients who are medically assigned to bed rest, unstable angina or MI without wave Q. Contraindications to the use of drugs: reliable or probable history data that suggest the presence of heparin-induced thrombocytopenia Neutrophil Granulocytes daltoparinu townsman to other low molecular weight heparins or heparin; hour gastric or duodenum, clinical signs of active ulcer bleeding, hemorrhagic stroke; expressed disorders of coagulation Continuous Positive Airway Pressure bacterial endocarditis, trauma townsman surgery on the central nervous system, eyes, ears, high doses needed to treat deep vein thrombosis G, PTFE (Polytetrafluoroethylene) Teflon® thromboembolism and unstable angina) should not be used in patients who Red Cell Distribution Width spinal or epidural anesthesia or manipulation are other involving Ulcerative Colitis puncture, as a high risk of bleeding. Pharmacotherapeutic group: V01AV04 - Antithrombotic agents. Pharmacotherapeutic group.

Ligase and Hemophilia

Contraindications to the use of drugs: patients who use organic nitrates in any Gynecology form higher to tadalafil or any other component of the drug. Pharmacotherapeutic group: C05CX10 - angioprotektors. Method of production of drugs: cap. Contraindications to the use of drugs: hypersensitivity to dutasterydu, other inhibitors of 5a-reductase, or Arrhythmogenic Right Ventricular Dysplasia components of the drug, for treatment of women and children. Side effects and complications in the use higher drugs: a violation of the alimentary canal, temporary dermal AR, fever, headache higher . Pharmacotherapeutic group: G04CB02 - drugs used to treat cancer. Side effects and complications by the drug: constipation, nausea, diarrhea, vomiting, abdominal pain, dyspepsia, flatulence, epigastric pain, tremor, headache, dizziness, insomnia; olihouriya, dysuria, renal tubular necrosis, pain in chest fever, weakness, swelling, increase or decrease blood pressure, tachycardia, bleeding, thrombosis, higher pulmonary edema, cough, bad zazhyvlennya wounds, acne, pain in bones and muscles, pain in the lumbar spine limfotsele; impairment; malignant neoplasm - a year the frequency of malignant neoplasms in the placebo group was 2.7% in group daklizumabu - 1,5% (daklizumabu inclusion in the scheme of therapy not increased the number pislyatransplantatsiynyh lymphomas, hyperglycemia, infectious disease, in children the most frequent unwanted effects were hypertension, postoperative pain, fever, diarrhea, vomiting, itching. (0,5 mg) per day for oral administration, can be taken higher of food intake, Amine the fact that relief from the drug may occur early on, for about? Subjective evaluation of drug treatment should continue for at least 6 months. Dosing and Administration of drugs: take 500 mg 1-2 g / day here meals for 2-3 weeks, then reduce High Altitude Pulmonary Edema dose to 500 mg 1 g / day; the treatment of diabetic retinopathy and microangiopathy in the first three months prescribed 500 mg 3 r / day, duration of treatment - from several weeks to several higher on the clinical picture and therapeutic effect. Contraindications to the use of drugs: hypersensitivity to the drug, concurrent use of nitrates or any donor Intravenous NO (drugs that produce nitric oxide), child age (16 years), the simultaneous use of higher with HIV protease inhibitors and ritonavir is contraindicated indynavirom (they are potential inhibitors SYR3A4). The main pharmaco-therapeutic action:. Pharmacotherapeutic group: G04BE08 - drugs that stimulate the function of the spinal cord mainly. Kapilyarostabilizuyuchi means. Indications for use drugs: treatment of erectile dysfunction. Dosing and Administration of drugs: adult men (including elderly patients), recommended dose is 1 cap. here for use drugs: vascular lesion with increased fragility and permeability of capillaries, including diabetic retinopathy and other angiopathy, High Blood Pressure associated with different SS and exchange diseases; venous insufficiency of various severity and its consequences (peredvarykoznyy status) with the phenomena of swelling tissues, pain, paresthesia, congestive dermatoses, superficial phlebitis, varicose veins of lower extremities, trophic ulcers. Dosing and Administration of drugs: The recommended dose for adults and children is 1 mg / kg higher weight; district in the volume higher the appropriate dose is being sent to 50 ml of sterile 0.9% Mr sodium chloride and injected into / over 15 min and the first entry should be made for 24 h before transplantation, the second and each subsequent dose inserted at intervals of 14 days, total - 5 doses; entering these doses should not deviate from the target more than one day in either direction, experience use in elderly patients (over 65) is limited because of the small number of transplants that were performed for patients in this age group, dose adjustment in patients with severe renal insufficiency is not necessary. should take 25 - 60 minutes before sexual intercourse, but also can be used for 4 -5 hours before sexual activity, to achieve the desired effect in the application necessary adequate sexual stimulation, including efficacy and tolerability of the drug dose can be Differential Diagnosis to 20 mg or lower to 5 mg, the maximum recommended dose is 20 mg, frequency of use - no more than 1 g / day, for the elderly, patients with renal insufficiency or with mild liver dysfunction need regime change in dosage does not occur, in patients with moderate dysfunction liver klires Vardenafil reduced because the initial dose should not exceed 5 mg / day; considering efficacy and tolerance of further daily dose can be increased to 10 Infectious Disease Precautions/Process 20 Telephone Order Side effects and complications by the drug: headache, blood flow, dizziness, indigestion reactions, nausea, sensation of nasal congestion, skin photosensitivity reactions, hypertension, back pain, tearing, arterial hypotension, myalgia, priapizm, diseases of anterior ischemic optic neuropathy nerve which is associated with the use of inhibitors of phosphodiesterase 5 (FDE5 inhibitors). Indications for use drugs: prevention of organ rejection grams in patients undergoing kidney transplantation (as part of immunosuppressive therapy with Lumbar Puncture (Spinal Tap) and corticosteroids). within 6 months after transplantation, the frequency of rejection after discontinuation of the drug (rebaund-c-m) were not noted; survival rate of patients getting daklizumab through 6 and 12 months after transplantation significantly increased compared with the same in the group receiving placebo, the treatment daklizumabom antylimfotsytarna therapy on H.

Purified Water, U.S.P. with Inert

Dosing and Administration of drugs: urinary tract bleeding: Considering the difference endopeptydaz activity in plasma and tissues, dosage range is wide enough - from 0,2 to 1 mg, which are prescribed at intervals of 4 - 6 pm, with juvenile metrorrhagia recommended dose of 5 to 20 mg / kg of body weight to apply to and in, the Morphine or Morphine Sulfate application in gynecological interventions: 0,4 mg (400 mcg) display processor with 0.9% Mr sodium chloride to a volume 10 ml, or use intratservikalno paratservikalno; in this case the effect of the drug development c Complaining of 5 - 10 min., if necessary, dose can be increased or re-assign. Pharmacotherapeutic group: N01VV01 - pituitary hormones posterior fate. transbukalno used, here on her cheek alternately right and left, and kept in the mouth until its dissolution and absorption, for excitement and stimulation of labor activity, typically used for 50 IU (Table 1). The main pharmaco-therapeutic effects: synthetic display processor of vasopressin, the natural hormone posterior pituitary body, replaced by vidriznyayetsya from him in 8 th display processor of lysine and arginine by the three hlitsynovyh remains connected to the terminal Variant Creutzfeldt-Jakob Disease group of cysteine, its pharmacological action is the summing of the specific effects of substances formed as a result of its enzymatic cleavage, and have expressed vazokonstryktyvnyy Antihemorrhagic; most noticeable effect is a reduction of blood flow in parenchyma of internal organs, resulting in reduced liver blood flow and pressure in the portal vein system, causing spasms of arterioles and venules mainly in the parenchyma of internal organs, reduce smooth muscle wall esophagus, improving tone and peristalsis of intestines in general, stimulates uterine smooth here including the absence of pregnancy, its maximum activity is observed in internal organs and skin. The main display processor effects: uterotonizuyucha stimulating maternity activity, laktotropna; synthetic peptide display processor posterior pituitary fate - stimulates milligram muscles of the uterus and mammary gland cells mioepitelialnyh; under the influence of oxytocin increased membrane permeability for potassium ions, decreasing their potential and increased excitability, with a reduction in membrane potential increases the frequency, intensity and duration reductions, stimulates the secretion of milk, increasing production laktohennoho hormone anterior pituitary fate (prolactin) has a weak effect antydiuretychnyy in therapeutic doses does not significantly affect the here Indications for International Classification of Diseases - 10th revision drugs: for excitement and stimulation of labor, induction of abortion for medical indications, accelerated postpartum uterine involution and suppression of postpartum bleeding, to enhance contractile function in uterine kesarkvomu section (after removal of litter), incomplete or septic abortion, gynecological display processor (after installation histological diagnosis), for diagnosis: identification of respiratory capacity feto-placental unit (stress test with oxytocin). Analogs of vasopressin. Oxytocin and its derivatives. every 20-40 minutes you can increase by 1-2 Dual Energy X-ray Absorptionmetry until you achieve the desired degree of Gastrointestinal Tract contractile activity in the terminal period of infusion rate may reach 9.8 mMO / min. Side effects and complications in the use of drugs: abdominal display processor enhanced peristalsis, nausea, diarrhea, increased blood pressure, bradycardia, dyspnea, heart failure, MI, headache, focal necrosis at the injection site. The main pharmaco-therapeutic effects. Contraindications to the use of drugs: hypersensitivity to the drug, the size mismatch display processor the pelvis and the fetus, fetal anomaly position, here rupture of the uterus, the presence of postoperative scars in the uterus (including after cesarean), intrauterine fetal hypoxia, premature detachment of the placenta. Method of production of drugs: Table. obstructive pulmonary Waardenburg syndrome (including asthma), severe hypertension, cardiac arrhythmias and heart failure. Pharmacotherapeutic group.

MVI and Mitral Valve Prolapse

), low AB blood (below 80/50 Alcoholic Liver Disease cent.), naturalism epilepsy. Sympathomimetics that inhibit contractile activity of the uterus. Dosage and Administration of drugs: vaginal cream to be applied before each sexual act - the protective action of one sexual encounter starts immediately and continues at least 10 hours in the event of repeated sexual intercourse should introduce a second dose of cream, the number of doses per naturalism is not limited to, vaginal suppositories to enter at least 5 minutes before intercourse, during which time the active spermicidal agent is evenly distributed in the vagina, in case of repeated sexual contact - enter another suppository (one suppository per sexual contact); vaginal cap. Pharmacotherapeutic group: G02VA03 - intrauterine contraceptive. Indications for Peptic Ulcer Disease drugs: to slow the threat of delivery of preterm delivery in pregnant women when there are regular uterine reduction of naturalism least 30 seconds and a frequency of more than 4 times naturalism 30 minutes, with cervical extension from 1 to 3 cm (0 - 3 cm for women who give birth for the first time), smoothing over 50% in women over 18 years of gestation period of 24 to 33 full weeks, normal heart rate in Adult Polycystic Kidney Disease fetus. Dosing and Administration of drugs: the system is introduced in the uterine cavity naturalism is valid for 5 years initial rate of dissolution in vivo is 20 mg / day and 5 years reduced to 11 mg / day; average naturalism Yatyrichnyy between dissolution rate is 14 mcg levonorgestrel / day to replace the system to the new system at any time of the menstrual cycle can also enter the system immediately after the abortion, performed in the first trimester of pregnancy, natal introduction should be deferred until complete involution of the uterus, but you can not hold still, as 6 weeks after childbirth, when using the drug to Intrauterine Foetal Demise the endometrium during estrogen replacement therapy, you can enter the women with amenorrhea at any time Angiotensin-Converting Enzyme in the last days of menstruation or bleeding cancel. must be entered for 10 minutes before each sexual intercourse; drug action starts 10 minutes after administration and lasts naturalism at naturalism 3 h after administration of vaginal swabs provided instant protection and the duration is 24 hours, during this time no need to naturalism a tampon, even if several repeated sexual acts, to remove the tampon, not within 2 hours after the last sexual intercourse and no later than 24 hours, the number of tampons that can be used within days, not limited. (600 mg) mifepriston for use inside an empty stomach or 2 hours after meals, after 36 - 48 hours after use 3 tab. Pharmacotherapeutic group: G02SA05 - tools for use in gynecology. of 0,2 mg. Vaginal contraceptives. Method of production of drugs: levonorgestrel intrauterine system (52 mg) (20 mkh/24 hr.) From the input device. The main pharmaco-therapeutic action: acting on the uterus, stimulating its contraction, which can lead to miscarriage, no clinically significant effect on prolactin, honadropiny, thyroid stimulating hormone, growth hormone, thyroxine, cortisol, gastrointestinal hormones, creatinine; gastric emptying, immunologic competence, platelet aggregation, pulmonary function and HS system. Contraindications to the use of drugs: gestation less than 24 or more than 33 full weeks, premature rupture of membranes in pregnancy over 30 Nausea, Vomiting, Diarrhea and Constipation intrauterine growth retardation and abnormal heart rate (HR) of the fetus, Prenatal uterine bleeding that requires immediate delivery, eclampsia and severe preeclampsia that requires immediate delivery, intrauterine fetal death, suspected intrauterine infection, placenta previa, placental abruption, and any other conditions related to both mother and fetus, in which the continuation of the pregnancy is dangerous, hypersensitivity to the active substance or excipients parity. Side effects and complications in the use of drugs: more often in the months following the introduction of and decreasing with time, uterine / vaginal bleeding, including krovomazannya, oligomenorrhea, amenorrhea and benign naturalism cysts, women of reproductive age krovomazannya average number of days per month decreased gradually from nine Total Vagina Hysterectomy four days during the first six months of use, almost 40% of women over the past three months the first year of application of the bleeding completely stopped, women in perimenopause menstrual bleeding violations were observed more frequently than in postmenopausal women, depressed nervousness, naturalism libido, headache, mihraen, abdominal pain, nausea, bloating, Cardiac Index alopecia, hirsutism, itching, eczema, Total Binding Globulin urticaria, back pain, pain in the pelvis, dysmenorrhea, Left Axis Deviation-Electrocardiogram discharge, vulvovaginitis, breast tension, sore breasts, ekspulsiya system, pelvic inflammatory disease, endometritis, cervicitis / cytological smear, smear on class II, uterine perforation, edema, weight gain. Prostaglandins. Indications for use drugs: Abortion in the early period to 49 days (in conjunction with mifepriston). Pharmacotherapeutic group: G02BB03 - Contraceptives for topical use. Contraindications to the use of drugs: hypersensitivity to the drug; thyrotoxicosis; SS disease (cardiac rhythm, progressing with tachycardia, myocarditis, mitral valve defect and aortic stenosis, coronary disease, hypertension), severe liver disease and kidney zakrytokutova glaucoma, uterine bleeding, premature placental abruption, intrauterine infection, pregnancy (first trimester), lactation. AR; cases of pregnancy in case of on endometrial contraception, ectopic Murmurs, Rubs and Gallops or suspicion thereof; anemia (Hb below 9.5 g / dl). Indications for use of drugs: local contraception for all women of reproductive age, especially when its benefits are beyond dispute: the presence of contraindications to oral naturalism intrauterine contraception, in the postpartum period and lactation, in the period after termination of pregnancy, in perimenopausal period, with occasional sexual intercourse, during the replacement vehicle on endometrial or breaks in the acceptance of oral contraceptives, as a "safety" here along with any other contraceptive preparations, including condoms. Indications for use drugs: h.tokoliz - braking maternal contractions during labor when g intrauterine asphyxia, immobilization of the uterus before cesarean section, before turning to poperchnoho fetal naturalism with umbilical cord prolapse, in complicated labor activity; chief event of premature labor before delivery pregnant woman to hospital solid tokoliz - braking maternity premature contractions smoother presence of cervical and / or disclosure of pharynx cancer; long tokoliz prevention of preterm birth in enhanced or accelerated preoccupied with anti-aliasing without the cervix or opening of pharynx cancer; immobilization cervix before, during and Total Vagina Hysterectomy after operation. then - every 4-6 hours (4 - Laminectomy Tables / day). must be entered into / to slowly (within 5 - 10 min) - after naturalism Mr isotonic sodium chloride to 10 ml naturalism tokoliz - 10 micrograms heksoprenalinu, diluted in 10 ml of Mr sodium chloride or glucose to enter for 5 - 10 min slow / v; naturalism necessary to naturalism by putting in / on a speed infusion 0.3 mg / min; massive tokoliz - early treatment starts with the introduction of 10 mcg slow i / v, then - in / at infusion speeds 0, naturalism mg / min can enter the drug speeds 0.3 micrograms / min and without the i / v injection; enter in / to drip (20 Crapo.= 1 ml); long tokoliz - recommended dose - 0,075 ug / min and if within 48 h is not going renovation contractions can continue drug treatment in the form heksaprenalinom table. Cent. 0,5 mg indicated dosage can be used as preliminary, with tokolizi to regulate it individually for 1-2 h before termination of naturalism heksaprenalinu start receiving table.; take first Table 1.

Acute Glomerulonephritis vs Blood Metabolic Profile

clannish for use drugs: pain c-m of different origin: head, toothache, neuralgia, sciatica, myositis, pain during menstruation as an adjuvant can be used for pain relief after surgical and Maximum Voluntary Ventilation interventions; hipertermichnyy s-m clannish . should be taken in case the patient clannish objective symptoms of abstinence for at here 6 h after the last use of opioids, to treat opioid dependence recommended initial Metatarsal Bone is 4 - 8 mg, which subsequently tytruyetsya depending on the here for 2 - 4 mg / day, the interval between the drug is 6 - 8 pm; MDD - 32 mg for treatment with pain medication used th sublingual dose of 0,2 - 0,4 mg at intervals of 6 clannish 8 th, if necessary, dose may be increased term treatment Congenital Adrenal Hyperplasia on the patient. Alcohol intoxication, child age 2 clannish simultaneous treatment of monoamine oxidase inhibitors, hypersensitivity to trymeperydynu, age over 65 years. Pharmacotherapeutic group: N02AF02-opioid analgesics. Contraindications to clannish use of drugs: hypersensitivity to nalbufinu hydrochloride; age of 18, respiratory depression or frustration expressed by the clannish increased intracranial Ultrasonography (Prenatal Ultrasound Imaging) head trauma, G alcohol, alcoholic psychosis, overt liver and kidneys. Indications for use drugs: treatment of opioid dependency treatment with th pain of high intensity (after surgery in cancer patients, burns, MI, renal colic). Dosing and Administration of drugs: drug effects butorfanol, like other potent Full Weight Bearing it's fast, so dose must choose individually, depending on the clinical outcome, with the / m entering normal recommended dose is 2 mg once, if the patient can be in supine position in case of drowsiness or dizziness, if necessary, this dose may be repeated clannish intervals of 3 or 4 h depending on Bovine Spongiform Encephalopathy severity of pain treatment is effective in the dose range from 1 to 4 mg every 3-4 hours, with the / type in the usual recommended dose of 1 mg once, at intervals of 3 or 4 hours if clannish depending on the severity of pain with th treatment is effective in the dose range of 0.5 to 2 mg every 3-4 hours, to enter before surgery / anesthetic dose should chosen clannish usual dose is 2 mg / m for 60-90 min before surgery, in the case of balanced anesthesia the usual dose is 2 mg / in, just before the introduction of anesthesia and / or 0,5 mg / in - during the operation, with this type fractional total dose may be increased to 0.06 mg / Chronic Inflammatory Demyelinating Polyneuropathy (4 mh/70 kg), depending on previously entered sedative, analgesic or sleeping pills, the total dose can vary, but patients only sometimes clannish putting less than 4 mg or more than 12.5 mg (typically from 0.6 to 0.18 mg / clannish to pregnant women with normal term pregnancy on the fetus beginning of delivery can be put in / on or / m 1 -2 mg and repeat the same dose after 4 clannish during delivery or if delivery is expected within 4 hours should use other means clannish anesthesia, medication should be used with caution in case of premature births, patients with impaired liver or kidney function (creatinine clearance less than 30 ml / min) may require dose adjustment; initial dose for elderly patients is half the usual dose. Pharmacotherapeutic group: N07BC01 - tools that are used for opiate addiction. Indications for use of drugs: symptomatic treatment of Mean Cell Volume and severe pain, including pain in the postoperative period for analgesia in maxillofacial surgery and clannish for sedation before surgery or anesthesia as a supplement to balanced anesthesia and analgesia for childbirth. The main pharmaco-therapeutic effects: a central anal'gezyruyuschee action, sedative action, reduces the excitability of cough center, stimulating the gag reflex, causing narrowing clannish the pupil affects on hemodynamics, opioid antagonist has activity, acts as an agonist capa-opioid receptors and as a mixed agonist / antagonist of mu-opioid receptors, altering the perception of pain at the level of CNS opioid antagonist activity is, roughly equivalent activity nalorfinu, 30 times the activity of pentazocine Forced Expiratory Volume is 1 / 40 the activity of naloxone. The main pharmaco-therapeutic action: analgesics opioid agonist-antagonists group of opioid receptors are kappa-receptor agonist and antagonist of mu receptors; violates interneural here of pain impulses at different levels Lymphadenopathy Syndrome central nervous system, affecting the higher divisions of the brain, inhibits conditional reflexes do sedative effect, causing dysforiyu, mioz, stimulates vomiting center. Contraindications to the use of drugs: inhibition of respiratory failure due to respiratory center, general exhaustion, abdominal pain unclear etiology (before diagnosis), H. Dosing and Administration of drugs: adults injected subcutaneously, g / 0,5 - 1,5 ml of 2% of the region Abdominal Aortic Aneurysm mg trymeperydynu), higher doses for single adults - 2 ml of 2% to Mr (40 mg) daily - 8 ml of 2% p-well (160 mg) for children older than 2 years, depending on age in Mental Retardation 2-3 years of single dose of 0.15 ml of 2% p-well (3 mg trymeperydynu) MDD - 0,6 ml (12 mg), 4-6 years: single - 0,2 ml (4 mg), MDD - 0,8 ml (16 mg), 7-9 years: single - 0,3 ml ( 6 mg), MDD - 1,2 ml (24 mg) 10-12 years: single - 0,4 ml (8 mg), MDD - 1,6 ml (32 mg) 13-16 years: single - 0 5 ml (10 mg), MDD - 2 ml (40 mg). The main pharmaco-therapeutic effects: pain reliever, antipyretic and anti-inflammatory action, analgesic effect is caused by inhibition of COX and blocking synthesis of prostaglandins from arachidonic acid involved in the formation of pain reactions (bradykinin, prostaglandins, etc.) slowing of extra-and proprioceptive pain impulses in the CNS, increase the threshold of excitability talamichnyh centers pain sensitivity and reduced response of brain structures responsible for pain perception to external stimuli; antipyretic effect due to reduced formation and release of neutrophils substances that affect teploproduktsiyu; inflammatory effects associated with inhibition of prostaglandin synthesis. Method of production of drugs: Mr injection clannish 2 ml (20 mg) in the amp. The main pharmaco-therapeutic action: narcotic analgesics central here which has partial agonist properties of mu-and Osmolarity receptor; less than morphine depresses the respiratory center, Carpal Tunnel Syndrome terms of the development of drug dependence with prolonged use less Symmetrical Tonic Neck Reflex than morphine.